Table of Contents Table of Contents
Previous Page  87 / 490 Next Page
Information
Show Menu
Previous Page 87 / 490 Next Page
Page Background

SATURDAY 30 APRIL 2016

85

SCIENTIFIC PROGRAMME

| PROGRAMME AND EXHIBITION GUIDE

17:00 > A simple visual test is adequate for testing vmDIBH reproducibility

in locoregional breast cancer

L.A. Den Otter (The Netherlands), T.T. Nuver, M. Boerhof, H.H.

Kolkman-Nijland, W.J. Schoevers, K. Muller, A.W.H. Minken

OC-0168

17:10 > Patient information through group sessions to improve knowledge

regarding breast cancer radiotherapy

M.T.A. Tinggaard Axelsen (Denmark), M.J. Jensen, B.H. Haislund,

H.M.N. Melgaard Nielsen

OC-0169

17:20 > Detection of setup errors with body surface laser scanning system

for whole breast irradiation

P. Jiang (China), Z. Liu, J. Wang, S. Zhou, J. Li, H. Sun, S. Jiang

OC-0170

Poster Viewing:4

PHYSICS: TREATMENT PLANNING: APPLICATIONS III

16:30 - 17:30 | POSTER AREA

Chair: S. Petit (The Netherlands)

Chair: M. Söhn (Germany)

> Can protons reduce bone marrow toxicity in definitive

chemoradiotherapy for oesophageal tumours?

S. Warren (UK), C. Hurt, T. Crosby, M. Partridge, M. Hawkins

PV-0171

> Selecting patients with lung cancer for proton therapy should be based

on multivariable NTCP models.

M.C.A. Kramer (The Netherlands), A.G.H. Niezink, E.W. Korevaar,

R.G.J. Kierkels, H.P. Van der Laan, A. Van der Schaaf, V.C. Hamming,

P. Kalk, J.A. Langendijk, J. Widder

PV-0172

> Dosimetric assessment of three-source Co-60 and Linac-based lung

SBRT for feasibility of MR-IGRT

N. Dogan (USA), N. Lamichhane, A. Ishkanian

PV-0173

> Experimental verification of 4D Monte Carlo calculations of dose

delivered to a moving anatomy

J. Cygler (Canada), S. Gholampourkashi, J. Belec, M. Vujicic, E. Heath

PV-0174

> Knowledge-based DVH predictions for automated individualised

treatment plan quality assurance

J. Tol (The Netherlands), M. Dahele, A. Delaney, B. Slotman, W. Verbakel

PV-0175

> Evaluation of biologically effective dose in stereotactic radiotherapy

for prostate cancer

T. Viren (Finland), T. Lahtinen, J. Hopewell, J. Seppälä

PV-0176